Answers are grounded in this paper and cite their sources.
Catalyst activation is explored through chlorido abstraction in oxidorhenium(V) complexes featuring phenolate-pyrazole ligands.
Here, the uploaded data is associated with the manuscript "Phenolate-pyrazole ligands in oxidorhenium(V) complexes: catalyst activation by chlorido abstraction” published in Inorganic Chemistry, 2026, 65(23), 13198–13205. DOI: 10.1021/acs.inorgchem.6c01732 The .csv files represent NMR, IR, UV-Vis and EI or ESI-MS spectra of the compounds published in the manuscript. The labeling of the compounds follows the one in the publication.
No takes yet. Share an insight, caveat, or question.
Jörg A. Schachner (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: